By Professor Richard John Epstein

Journal articles

Epstein RJ, 1992, 'Does the breast cancer dollar make sense?', European Journal of Cancer, 28, pp. 486 - 491, http://dx.doi.org/10.1016/S0959-8049(05)80084-X

Epstein RJ; Druker BJ; Irminger JC; Jones SD; Roberts TM; Stiles CD, 1992, 'Extracellular calcium mimics the actions of platelet-derived growth factor on mouse fibroblasts.', Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research, 3, pp. 157 - 164

Epstein RJ; Druker BJ; Roberts TM; Stiles CD, 1992, 'Synthetic phosphopeptide immunogens yield activation-specific antibodies to the c-erbB-2 receptor', Proceedings of the National Academy of Sciences of the United States of America, 89, pp. 10435 - 10439

Epstein RJ; Druker BJ; Roberts TM; Stiles CD, 1990, 'Modulation of a Mr 175,000 c-neu receptor isoform in G8/DHFR cells by serum starvation', Journal of Biological Chemistry, 265, pp. 10746 - 10751

Epstein RJ, 1990, 'Drug-induced DNA damage and tumor chemosensitivity', Journal of Clinical Oncology, 8, pp. 2062 - 2084

Epstein RJ; Smith PJ, 1989, 'Mitogen-induced topoisomerase II synthesis precedes DNA synthesis in human breast cancer cells', Biochemical and Biophysical Research Communications, 160, pp. 12 - 17, http://dx.doi.org/10.1016/0006-291X(89)91613-6

Epstein RJ, 1989, 'Drug wars in the United States', British Medical Journal, 299, pp. 1275 - 1276, http://dx.doi.org/10.1136/bmj.299.6710.1275

Epstein RJ; Smith PJ; Watson JV; Waters C; Bleehen NM, 1989, 'Oestrogen potentiates topoisomerase‐II‐mediated cytotoxicity in an activated subpopulation of human breast cancer cells: Implications for cytotoxic drug resistance in solid tumours', International Journal of Cancer, 44, pp. 501 - 505, http://dx.doi.org/10.1002/ijc.2910440321

Epstein RJ, 1988, 'TOPOISOMERASES IN HUMAN DISEASE', The Lancet, 331, pp. 521 - 524, http://dx.doi.org/10.1016/S0140-6736(88)91308-6

Epstein RJ; Smith PJ; Watson JV; Bleehen NM, 1988, 'Characterisation of VP-16-induced DNA cleavage in oestrogen-stimulated human breast cancer cells', British Journal of Cancer, 57, pp. 445 - 450, http://dx.doi.org/10.1038/bjc.1988.104

Epstein RJ; Smith PJ, 1988, 'Estrogen-induced potentiation of dna damage and cytotoxicity in human breast cancer cells treated with topoisomerase ii-interactive antitumor drugs', Cancer Research, 48, pp. 297 - 303

Epstein RJ; Watson JV; Smith PJ, 1988, 'Subpopulation analysis of drug‐induced cell‐cycle delay in human tumor cells using 90° light scatter', Cytometry, 9, pp. 349 - 358, http://dx.doi.org/10.1002/cyto.990090412

Epstein RJ, 1988, 'The clinical biology of hormone-responsive breast cancer', Cancer Treatment Reviews, 15, pp. 33 - 51, http://dx.doi.org/10.1016/0305-7372(88)90008-4

Epstein RJ, 1986, 'Is your initiator really necessary?', Journal of Theoretical Biology, 122, pp. 359 - 374, http://dx.doi.org/10.1016/S0022-5193(86)80127-8

EPSTEIN RJ; McNEILAGE LJ; GATENBY PA; HENDERSON‐SMART DJ; WHITTINGHAM SF; BASTEN A, 1985, 'INFANTILE COMPLETE HEART BLOCK ASSOCIATED WITH MATERNAL Ro(SS‐A) RIBONUCLEOPROTEIN AUTOANTIBODIES: REPORT OF TWO CASES', Australian and New Zealand Journal of Medicine, 15, pp. 58 - 61, http://dx.doi.org/10.1111/j.1445-5994.1985.tb02737.x

Epstein RJ; Joshua DE; Kronenberg H, 1985, 'Idiopathic myelofibrosis complicated by lymphoma. Report of two cases.', Acta Haematol, 73, pp. 40 - 44, http://dx.doi.org/10.1159/000206271

EPSTEIN RJ; OLIVER B; MACINTOSH PK; LEVI JA, 1984, 'COMPUTED TOMOGRAPHY OF INTRAPERITONEAL MALIGNANCY', Australian and New Zealand Journal of Medicine, 14, pp. 13 - 18, http://dx.doi.org/10.1111/j.1445-5994.1984.tb03577.x

Epstein RJ; Ogler RF; Gatenby PA, 1984, 'Lupus erythematosus and panhypogammaglobulinemia.', Ann Intern Med, 100, pp. 162 - 163, http://dx.doi.org/10.7326/0003-4819-100-1-162_3

Epstein RJ, 1980, 'What does prolactin do?', Lancet, 1, pp. 264, http://dx.doi.org/10.1016/s0140-6736(80)90759-x

Conference Papers

Emmett L; Joshua A; Epstein R; Chalasani V; Kneebone A; Hruby G; O'Neill G; Stricker P; Stricker P; Quoc N; Ho B, 2018, 'Modulation of PSMA expression by Androgen deprivation therapy (ADT): Serial PSMA PET in men with hormone sensitive, and castrate resistant prostate cancer commencing androgen blockade', in JOURNAL OF NUCLEAR MEDICINE, SOC NUCLEAR MEDICINE INC, PA, Philadelphia, presented at Annual Meeting of the Society-of-Nuclear-Medicine-and-Molecular-Imaging (SNMMI), PA, Philadelphia, 23 June 2018 - 26 June 2018, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000467489900093&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Crumbaker M; Joshua AM; Epstein R; Emmett L, 2018, 'A phase I study of Lu-177-DKFZ PSMA 617 combined with the radiosensitizer idronoxil in men with metastatic castrate-resistant prostate cancer (mCRPC) (LuPin trial).', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, http://dx.doi.org/10.1200/JCO.2018.36.15_suppl.TPS5088

Sternberg CN; Saad F; Graff JN; Peer A; Vaishampayan UN; Leung E; Rosenbaum E; Gurney H; Epstein R; Davis ID; Wu B; Trandafir L; Wagner VJ; Hussain M, 2018, 'A randomized phase 2 study investigating 3 dosing regimens of radium-223 dichloride (Ra-223) in bone metastatic castration-resistant prostate cancer (mCRPC).', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, http://dx.doi.org/10.1200/JCO.2018.36.15_suppl.5008

Yau T; Wong H; Lau S; Leung R; Chiu J; Wong TT; Liang R; Epstein RJ; Cheung P, 2012, 'Comparison of Clinicopathologic Features of Invasive Lobular Carcinoma of the Breast with or Without Associated Lobular Carcinoma In-situ', in EUROPEAN JOURNAL OF CANCER, ELSEVIER SCI LTD, AUSTRIA, Vienna, pp. S179 - S179, presented at 8th European Breast Cancer Conference (EBCC), AUSTRIA, Vienna, 21 March 2012 - 24 March 2012, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000302804600460&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Wong H; Lau S; Cheung P; Leung R; Chiu J; Wong TT; Liang R; Epstein RJ; Yau T, 2012, 'Ki67 Proliferation Index in Invasive Lobular Carcinoma of the Breast - Clinicopathologic Correlation and Prognostic Significance', in EUROPEAN JOURNAL OF CANCER, ELSEVIER SCI LTD, AUSTRIA, Vienna, pp. S136 - S136, presented at 8th European Breast Cancer Conference (EBCC), AUSTRIA, Vienna, 21 March 2012 - 24 March 2012, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000302804600328&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Epstein RJ, 2010, 'INFLUENCE OF INCOME AND EDUCATION ON ANTICANCER DRUG PURCHASING DECISIONS IN HONG KONG CHINESE CANCER PATIENTS', in ANNALS OF ONCOLOGY, OXFORD UNIV PRESS, ITALY, Milan, pp. 369 - 369, presented at 35th European-Society-for-Medical-Oncology (ESMO) Congress, ITALY, Milan, 08 October 2010 - 12 October 2010, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000284592300406&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Yau T; Chan P; Wong H; Ng KK; Chok SH; Cheung TT; Lam V; Epstein RJ; Fan ST; Poon RTP, 2007, 'Efficacy and tolerability of low-dose thalidomide as first-line systemic treatment of patients with advanced hepatocellular carcinoma', in Oncology, pp. 67 - 71, http://dx.doi.org/10.1159/000111709

Conference Posters

Joshua AM; Stricker P; Epstein RJ; Ho B; Quoc N; Kent R; Willowson KP; Hofman M; Violet JA; Emmett L, 2017, 'Patterns of failure on Ga PSMA (GaPSMA) and F18 FDG (FDG) PET CT in a prospective phase 2 trial of Lu-177 DKFZ PSMA 617 (LuPSMA) in men with castrate resistant metastatic prostate cancer (mCRPC)', IL, Chicago, Vol. 35, presented at 53rd Annual Clinical Science Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Symposium on Old Targets, New Drugs - Her2 and MET, IL, Chicago, 02 June 2017 - 07 June 2017, http://dx.doi.org/10.1200/JCO.2017.35.15_suppl.2562

Manders PM; Cowley M; McCabe M; Madigan M; Munoz-Erazo L; Conway RM; Epstein RJ, 2015, 'MOLECULARLY-TARGETED AND IMMUNE STRATEGIES FOR PATIENTS WITH DRUG-RESISTANT UVEAL MELANOMA: AN UNMET AREA OF NEED IN PERSONALIZED ONCOLOGY', Vol. 11, pp. 58 - 58, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000357957300043&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Conference Presentations

Blackburn J; Ng R; Roden D; Wu J; Epstein RJ, 2014, 'Damage-inducible intragenic demethylation activates transcription of an alternative intronic promoter in TP53-wildtype but not mutant human cells and tumors', presented at 105th Annual Meeting of the American-Association-for-Cancer-Research (AACR), CA, San Diego, 05 April 2014 - 09 April 2014, http://dx.doi.org/10.1158/1538-7445.AM2014-LB-85

Conference Abstracts

Lin FP; Salih OSM; Epstein RJ, 2018, 'EXPLORATORY ANALYSIS OF CLINICAL PROGNOSTIC FACTORS IN PATIENTS WITH ADVANCED CANCER USING COMPUTATIONAL TEXT MINING OF ROUTINE DIGITISED ONCOLOGY CORRESPONDENCE', in INTERNAL MEDICINE JOURNAL, WILEY, Vol. 48, pp. 8 - 8, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000431995500009&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Lin FP-Y; Martin C; Kocbek S; Joshua AM; Dear RF-G; Lim E; Chantrill LA; Chin VT; Epstein RJ, 2017, 'Identifying determinants of quality of life in patients undergoing systemic therapy for solid tumors.', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, IL, Chicago, Vol. 35, presented at 53rd Annual Clinical Science Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Symposium on Old Targets, New Drugs - Her2 and MET, IL, Chicago, 02 June 2017 - 07 June 2017, http://dx.doi.org/10.1200/JCO.2017.35.15_suppl.6596

Lin FP-Y; Groza T; Kocbek S; Antezana E; Epstein RJ, 2017, 'The Cancer Care Treatment Outcomes Ontology (CCTO): A computable ontology for profiling treatment outcomes of patients with solid tumors.', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, IL, Chicago, Vol. 35, presented at 53rd Annual Clinical Science Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Symposium on Old Targets, New Drugs - Her2 and MET, IL, Chicago, 02 June 2017 - 07 June 2017, http://dx.doi.org/10.1200/JCO.2017.35.15_suppl.e18137

Lin FPY; Pokorny A; Teng C; Dear R; Epstein RJ, 2016, 'AN ALTERNATING DECISION TREE MODEL FOR PREDICTING MULTIDISCIPLINARY TEAM MEETING DECISION ABOUT ADJUVANT CHEMOTHERAPY IN EARLY BREAST CANCER PATIENTS', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY-BLACKWELL, Vol. 12, pp. 59 - 59

Ding P; Tai J; Manders P; Stone E; Ho B; Epstein R, 2015, 'Dependence of fluorodeoxyglucose avidity on tumour size in non-small cell lung cancer', in ANNALS OF ONCOLOGY, OXFORD UNIV PRESS, SINGAPORE, Singapore, Vol. 26, pp. 153 - 154, presented at Asia Congress of the European-Society-for-Medical-Oncology (ESMO), SINGAPORE, Singapore, 18 December 2015 - 21 December 2015, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000367158700499&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Ding P; Tai J; Manders P; Stone E; Ho B; Epstein R, 2015, 'DEPENDENCE OF FLUORODEOXYGLUCOSE (FDG) AVIDITY ON TUMOUR SIZE IN NON-SMALL CELL LUNG CANCER (NSCLC)', in Asia-Pacific Journal of Clinical Oncology, WILEY-BLACKWELL, Vol. 11, pp. 121 - 121, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000364320800171&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Reports

Shrosbree J; Pokorny A; Stone E; Epstein R; Mccormack A; Greenfield JR, 2016, Ectopic Cushing syndrome due to neuroendocrine prostatic cancer, http://dx.doi.org/10.1111/imj.13063

Patents

Epstein R; Druker B; Stiles C, 1996, Production of activation-state-specific antibodies using synthetic phosphopeptide immunogens, Patent No. 08/324421

Preprints

Lin FPY; Salih OSM; Scott N; Jameson MB; Epstein RJ, 2020, Repurposing digitised clinical narratives to discover prognostic factors and predict survival in patients with advanced cancer, http://dx.doi.org/10.1101/2020.10.28.20214627

Back to profile page